Natur Holdings B.V. entered into a non-binding letter of intent to acquire Future Healthcare of America (OTCPK:FUTU) from several shareholders in a reverse merger transaction on May 18, 2018. The letter of intent contemplates that the current business of Future Healthcare will be sold either prior to or after the closing of the definitive agreement between the parties. Natur Holdings B.V. entered into a share exchange agreement to acquire Future Healthcare of America from several shareholders in a reverse merger transaction on September 21, 2018. It is anticipated that the stockholders of Natur will own approximately 71% of Future Healthcare’s shares immediately following the closing of transaction, with the remaining 29% to be owned by Future Healthcare’s current stockholders, noteholders and lenders. The transaction is subject to numerous conditions including the negotiation and execution of a binding definitive agreement between the parties and due diligence. Branden T. Burningham of Burningham Law Group acted as the legal advisor to Future Healthcare whereas Andrew D. Hudders of Golenbock Eiseman Assor Bell & Peskoe LLP acted as the legal advisor to Natur Holdings on the transaction. Natur Holdings B.V. completed the acquisition of Future Healthcare of America (OTCPK:FUTU) from several shareholders in a reverse merger transaction on November 13, 2018. The former shareholders of Nature received the equivalent of 215.76 million shares of the common stock of Future Healthcare, which was issued in part as shares of common stock and in part as voting, convertible shares of Series B Preferred Stock. The Series B Preferred Stock will convert on a one for one basis into common stock once Future Healthcare increases its authorized capital.